COVID-19 Testing for the Essential Workforce
Learn about our efforts to test people on the front line and how you can help.
NEWS
Team
MiraKind.org announces $50,000 donation from George and Loretta Whitesides for COVID-19 Testing at Los Angeles-area Skilled Nursing and Senior Care Facilities
Program Expands Efforts by Los Angeles-based Molecular Genetics Company MiraDx to Provide COVID-19 Tests to Essential Workers via Philanthropic Donations to its Sister Non-Profit LOS ANGELES (April 13, 2020) — Mirakind.org, a…
Read More
MiraKind supports essential workforce organizations with free COVID-19 Testing
MiraKind is ready to distribute COVID-19 tests for free to essential workers, with funding from the generous philanthropic donations of our MiraKind community through our #330MillionTests.org site. We are currently prioritizing access…
Read More
MiraKind Responds to the COVID-19 Pandemic
At MiraKind, we believe knowledge is power. That belief has never held truer than today, as we face a global pandemic that can only be stamped out with knowledge–knowledge of who is…
Read More
Dr. Joanne Weidhaas to speak at TEDxCulverCity
Our founder, Dr. Joanne Weidhaas will be giving her first “TED talk” as an invited speaker at TEDxCulverCity on March 31, 2020! Joanne is a radiation oncologist and cancer researcher, and she…
Read More
Let’s learn more about Hormone Replacement Therapy – together!
We want to start with the basics about Hormone Replacement Therapy, so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what Hormone…
Read More
New Partnership Alert: MiraKind & genneve
MiraKind is committed to providing our community with the best tools possible to tackle challenges in the arena of women’s health. This is why MiraKind is partnering with genneve, a first-of-its-kind telehealth…
Read More
More proof Hormone Replacement Therapy (HRT) is safe, effective, and beneficial for most women
When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing…
Read More
Important Findings From Our Recently Published KRAS-Variant Study
A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal…
Read More
New Research: “The KRAS-variant induces an epithelial-to-mesenchymal transition ‘EMT’ in normal breast epithelial cells”
As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information…
Read More
New Research: How Inherited DNA -Based Mutations Impact Immunotherapy
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we’ve spoken a lot…
Read More
International Women’s Day Profile: Dr. Joanne Weidhaas
Here at MiraKind, we’re constantly inspired by the amazing women who surround us; whether it is scientists and doctors working on our research, or the strong and empowered women who are facing complex health challenges with dignity and grace.
Read More
Part 2 Q&A: Meet the MiraDx Research Team
“We’re pivoting from being focused on the disease to being focused on the patient and providing the tools to personalize each individual’s treatment.” –Mattias
Read More